CAJ | 학술논문

食管腺癌发病率的增长速度居各种食管恶性肿瘤的第2位,目前认为Barrett食管是食管腺癌的一种癌前病变.Barrett食管的发病率与社会经济状况密切相关,在生活水平较高的发达国家,与Barrett食管相关的食管腺癌发病率迅速增长.Barrett食管的危险因素包括胃食管反流病、白人或西班牙裔种族、男性、年龄、吸烟、肥胖等.Barrett食管的治疗主要包括药物治疗、内镜治疗及外科手术治疗,但对Barrett食管有效的化学预防目前仍需进一步的临床随机试验加以阐明.
식관선암발병솔적증장속도거각충식관악성종류적제2위,목전인위Barrett식관시식관선암적일충암전병변.Barrett식관적발병솔여사회경제상황밀절상관,재생활수평교고적발체국가,여Barrett식관상관적식관선암발병솔신속증장.Barrett식관적위험인소포괄위식관반류병、백인혹서반아예충족、남성、년령、흡연、비반등.Barrett식관적치료주요포괄약물치료、내경치료급외과수술치료,단대Barrett식관유효적화학예방목전잉수진일보적림상수궤시험가이천명.
The growth rate of the incidence of Barrett's esophagus ranked the second place among all the malignant esophageal tumors,and Barrett's esophagus is a precursor of esophageal adenocarcinoma.The incidence of Barrett's esophagus is closely related to social economic status.In developed countries,the incidence of esophageal adenocarcinoma associared with Barrett's esophagus has been increased rapidly.The risk factors for Barrett's esophagus include gastroesophageal reflux disease,white or Hispanic race,male,age,smoking and obesity.The treatment of Barrett's esophagus mainly include drug therapy,endoscopic therapy and surgical treatment.The efficiency of chemoprevention of Barrett's esophagus still needs to be proved by further randomized clinical trials.